12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks saw significant movement. Gainers included Acorda Therapeutics (ACOR), Vivos Therapeutics (VVOS), Pasithea Therapeutics (KTTA), Enveric Biosciences (ENVB), 60 Degrees (SXTP), and Esperion Therapeutics (ESPR). Losers included MaxCyte (MXCT), Heart Test Laboratories (HSCS), Senti Biosciences (SNTI), Accolade (ACCD), Elutia (ELUT), and PDS Biotechnology (PDSB).
October 04, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Accolade shares fell 7.59% to $9.01. The company's Q2 earnings came out today.
The decrease in Accolade's share price following the release of its Q2 earnings indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
MaxCyte shares declined by 18.4% to $2.67 during Wednesday's after-market session.
The significant decrease in MaxCyte's share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Acorda Therapeutics stock increased by 29.5% to $14.5 during Wednesday's after-market session.
The significant increase in Acorda Therapeutics' stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Vivos Therapeutics shares moved upwards by 20.52% to $0.37.
The significant increase in Vivos Therapeutics' share price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100